Edinburgh, Scotland | April 26, 2026
While France deploys in-house 3D printing across all 3,000 hospitals and Germany invests heavily in surgical planning technology, Scotland’s healthcare system risks falling behind a precision medicine shift that is cutting operating times and improving patient outcomes, according to reporting from BioWorld and wider European market data.
The technology benefit in surgery
In-house 3D printing turns CT and MRI scans into patient-specific anatomical models that surgeons can hold, inspect and use to rehearse difficult procedures before entering theatre. That changes surgical planning from interpreting flat images on a screen to working with a physical replica of the exact anatomy, helping teams anticipate complications, choose the best approach and reduce uncertainty during the operation itself.
The clinical upside is increasingly clear. A review of 3D medical printing in surgery reports that the vast majority of clinicians see improved outcomes and reduced operating times when 3D-printed models or guides are used alongside imaging. Hospitals already using the technology in the UK have reported major gains: King’s College Hospital has cut hours off complex procedures using 3D planning models, while other centres report similar time savings in head and neck and spinal surgery. France’s expansion has also been backed by industrial deployment through Stratasys, which is working with Bone 3D to scale hospital access to the technology.
Beyond speed, the models let surgeons pre-bend implants, map screw placement and tailor tools before sterilisation, which can improve accuracy once the patient is on the table. Studies also associate 3D printing in surgical planning with lower blood loss, reduced fluoroscopy exposure, fewer repeat procedures and shorter anaesthesia time.
France and Germany move faster
France has adopted one of the clearest system-level approaches in Europe through the Hospifactory initiative, designed to give hospitals direct access to on-site 3D printing for devices, components and patient-specific models. That programme builds on earlier deployment in the French hospital system, including AP-HP in Paris, where dozens of 3D printers were used during the pandemic to produce more than 84,000 parts supporting patients and staff.
French hospitals are also building dedicated in-house capability. CHU de Brest launched its own 3D printing platform in 2023 and reports that surgeons are better prepared before theatre and surgical risk is reduced when they can plan with life-like anatomical models. France has also produced national good-practice guidance for in-house 3D printing in maxillofacial and oral surgery, signalling a level of operational maturity Scotland has not yet matched.
Germany offers a similar contrast. Its healthcare 3D printing market was valued at around USD 285.4 million in 2025 and is forecast to keep growing strongly, supported by public schemes intended to speed additive manufacturing in healthcare. German hospitals and researchers have shown that low-cost in-house setups can comply with regulation while saving time in theatre and improving outcomes in complex craniofacial and vascular cases.
Scotland’s slower progress
Scotland is not starting from zero, but the evidence points to scattered activity rather than a coordinated in-house surgical printing strategy. NHS Greater Glasgow and Clyde has highlighted 3D printing in its maxillofacial laboratory, and NHS Golden Jubilee has published research linked to 3D bio-printing, yet neither example amounts to the kind of national or multi-site surgical planning infrastructure seen in France or Germany.
That matters because the economic case is not abstract. Shorter procedures reduce expensive theatre time and can release capacity for more operations, which is especially relevant as NHS Scotland remains focused on productivity and waiting-list reduction. Recent hospital-sector data from European forums and case studies show operating times in some complex procedures falling from 8–12 hours to 2–3 hours, with savings running into thousands of pounds per case.
A stronger angle for Scotland
The real story for Scotland is not simply that 3D printing exists elsewhere, but that other European systems are treating it as core surgical infrastructure rather than a niche pilot. France and Germany show how engineering, imaging and clinical teams can be brought together around in-house production to improve surgical precision, cut time in theatre and make complex care more predictable.
For Scottish health boards, the lesson is clear: if 3D printing remains isolated to small pockets of innovation, Scotland risks missing out on a technology that is increasingly proving its value in surgery. The sharper editorial angle is therefore not admiration for overseas experimentation, but a question of whether Scotland is moving quickly enough to keep pace with a European shift already delivering measurable clinical and operational gains.
